Posts Tagged ‘Esbriet’

What’s at Stake?

What's at Stake with Humira?

Drug companies maximize the sales of new drugs by hyping their benefits while downplaying significant risks. In 2010 the European Medicines Agency began releasing patient-level data from the clinical trials used to approve new medicines in Europe – a development hailed by American, and European researchers and researchers around the world as a major step towards drug safety.

This process has been shut down by a lawsuit taken by two American corporations – AbbVie, makers of Humira, the number one selling medication in the world with projected sales of $10 billion in 2013; and InterMune, whose pulmonary-fibrosis drug Esbriet has recently been approved in Europe at a cost of over $40,000 per year.

Sign the petition here: Let us see Drug Data! Drug hazards are not “trade secrets”!

Read Dr. David Healy’s post here: Letter to Stacy London

Translations:
The posters are being translated into many languages including French, Dutch, Hindi, Kannada, Spanish, Mandarin, Italian, and German as part of RxISK‘s world-wide campaign for open data on pharmaceutical research and drug safety trials.

FrenchDutchHindiKannadaSpanishMandarinItalianGerman

 

Half-Truths

Half truths are more dangerous than lies

“There are many of us with bad Rheumatoid Arthritis or Crohn’s Disease who would gladly take these risks, especially if the drug produced a real benefit. We might be much less inclined to do for milder conditions. But in all cases the trade-off should be ours.

Ideally we should be helped by our doctors and pharmacists, but doctors and pharmacists who truly know what the problems can be. When AbbVie hide their clinical trial data, they make anyone who was involved in a clinical trial of their drug or a doctor prescribing it or pharmacist dispensing it into a potential accomplice to injury and perhaps homicide because the missing data is used to argue that ‘we’ve done trials and look there is no risk’.”

See full post: Lets do the AbbVie again by Dr. David Healy